These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 30955196)

  • 1. Serum immunoinflammation-related protein complexes discriminate between inflammatory bowel disease and colorectal cancer.
    Sun YH; Li J; Shu HJ; Li ZL; Qian JM
    Clin Transl Oncol; 2019 Dec; 21(12):1680-1686. PubMed ID: 30955196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Levels of Adipocytokines as Potential Biomarkers for Early Detection of Colorectal Carcinoma in Egyptian Patients.
    Zekri AR; Bakr YM; Ezzat MM; Zakaria MS; Elbaz TM
    Asian Pac J Cancer Prev; 2015; 16(16):6923-8. PubMed ID: 26514469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fragments of Citrullinated and MMP-degraded Vimentin and MMP-degraded Type III Collagen Are Novel Serological Biomarkers to Differentiate Crohn's Disease from Ulcerative Colitis.
    Mortensen JH; Godskesen LE; Jensen MD; Van Haaften WT; Klinge LG; Olinga P; Dijkstra G; Kjeldsen J; Karsdal MA; Bay-Jensen AC; Krag A
    J Crohns Colitis; 2015 Oct; 9(10):863-72. PubMed ID: 26188349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative assessment of mucosal architecture using computer-based analysis of confocal laser endomicroscopy in inflammatory bowel diseases.
    Quénéhervé L; David G; Bourreille A; Hardouin JB; Rahmi G; Neunlist M; Brégeon J; Coron E
    Gastrointest Endosc; 2019 Mar; 89(3):626-636. PubMed ID: 30120955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low Mass Blood Peptides Discriminative of Inflammatory Bowel Disease (IBD) Severity: A Quantitative Proteomic Perspective.
    Wasinger VC; Yau Y; Duo X; Zeng M; Campbell B; Shin S; Luber R; Redmond D; Leong RW
    Mol Cell Proteomics; 2016 Jan; 15(1):256-65. PubMed ID: 26530476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ulcerative colitis, Crohn's disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn's disease.
    Mortensen JH; Manon-Jensen T; Jensen MD; Hägglund P; Klinge LG; Kjeldsen J; Krag A; Karsdal MA; Bay-Jensen AC
    PLoS One; 2017; 12(10):e0185855. PubMed ID: 29028807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel, objective, multivariate biomarkers composed of plasma amino acid profiles for the diagnosis and assessment of inflammatory bowel disease.
    Hisamatsu T; Okamoto S; Hashimoto M; Muramatsu T; Andou A; Uo M; Kitazume MT; Matsuoka K; Yajima T; Inoue N; Kanai T; Ogata H; Iwao Y; Yamakado M; Sakai R; Ono N; Ando T; Suzuki M; Hibi T
    PLoS One; 2012; 7(1):e31131. PubMed ID: 22303484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiles of Lamina Propria T Helper Cell Subsets Discriminate Between Ulcerative Colitis and Crohn's Disease.
    Li J; Ueno A; Fort Gasia M; Luider J; Wang T; Hirota C; Jijon HB; Deane M; Tom M; Chan R; Barkema HW; Beck PL; Kaplan GG; Panaccione R; Qian J; Iacucci M; Gui X; Ghosh S
    Inflamm Bowel Dis; 2016 Aug; 22(8):1779-92. PubMed ID: 27243594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Fragment of Collagen Type VI alpha-3 chain is Elevated in Serum from Patients with Gastrointestinal Disorders.
    Holm Nielsen S; Mortensen JH; Willumsen N; Rasmussen DGK; Mogensen DJ; Di Sabatino A; Mazza G; Jørgensen LN; Giuffrida P; Pinzani M; Klinge L; Kjeldsen J; Leeming DJ; Karsdal MA; Genovese F
    Sci Rep; 2020 Apr; 10(1):5910. PubMed ID: 32245981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Red cell distribution width for assessment of activity of inflammatory bowel disease.
    Cakal B; Akoz AG; Ustundag Y; Yalinkilic M; Ulker A; Ankarali H
    Dig Dis Sci; 2009 Apr; 54(4):842-7. PubMed ID: 18716874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma Extracellular Vesicle LncRNA H19 as a Potential Diagnostic Biomarker for Inflammatory Bowel Diseases.
    Heydari R; Fayazzadeh S; Shahrokh S; Shekari F; Farsad F; Meyfour A
    Inflamm Bowel Dis; 2024 May; 30(5):795-807. PubMed ID: 37855715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neopterin in assessing the activity of inflammatory bowel diseases: ulcerative colitis and Crohn's disease].
    Ciećko-Michalska I; Fedak D; Mach T
    Przegl Lek; 2010; 67(12):1262-5. PubMed ID: 21591350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Calprotectin: A Novel Diagnostic and Prognostic Marker in Inflammatory Bowel Diseases.
    Kalla R; Kennedy NA; Ventham NT; Boyapati RK; Adams AT; Nimmo ER; Visconti MR; Drummond H; Ho GT; Pattenden RJ; Wilson DC; Satsangi J
    Am J Gastroenterol; 2016 Dec; 111(12):1796-1805. PubMed ID: 27596694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases.
    Nikolaus S; Schulte B; Al-Massad N; Thieme F; Schulte DM; Bethge J; Rehman A; Tran F; Aden K; Häsler R; Moll N; Schütze G; Schwarz MJ; Waetzig GH; Rosenstiel P; Krawczak M; Szymczak S; Schreiber S
    Gastroenterology; 2017 Dec; 153(6):1504-1516.e2. PubMed ID: 28827067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease.
    Karmiris K; Koutroubakis IE; Xidakis C; Polychronaki M; Voudouri T; Kouroumalis EA
    Inflamm Bowel Dis; 2006 Feb; 12(2):100-5. PubMed ID: 16432373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of bacterial biomarkers to aid in challenging inflammatory bowel diseases diagnostics and subtype classification.
    Lopez-Siles M; Aldeguer X; Sabat-Mir M; Serra-Pagès M; Duncan SH; Flint HJ; Garcia-Gil LJ; Martinez-Medina M
    World J Gastrointest Pathophysiol; 2020 May; 11(3):64-77. PubMed ID: 32435523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating miR-199a and long noncoding-RNA ANRIL as Promising Diagnostic Biomarkers for Inflammatory Bowel Disease.
    Erfan R; Shaker OG; Khalil MAF; Mahmoud FAM; Gomaa MS; Abu-El-Azayem AK; Zaki OM; Ahmed AM; Samy A; Mohammed A
    Inflamm Bowel Dis; 2024 Sep; 30(9):1500-1509. PubMed ID: 38190238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined analysis of serum SAP and PRSS2 for the differential diagnosis of CD and UC.
    Wang W; Wu L; Wu X; Li K; Li T; Xu B; Liu W
    Clin Chim Acta; 2021 Mar; 514():8-14. PubMed ID: 33333044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trefoil Factor 3 in human serum as a predictor of disease activity in Egyptian ulcerative colitis patients and its role in colorectal cancer.
    Hashem WM; Samy AH; Ali SA; Anwar CA; Abd El Malak MWN; Al-Ashram MNB
    Egypt J Immunol; 2024 Oct; 31(4):27-35. PubMed ID: 39404647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced formation of advanced oxidation protein products in IBD.
    Krzystek-Korpacka M; Neubauer K; Berdowska I; Boehm D; Zielinski B; Petryszyn P; Terlecki G; Paradowski L; Gamian A
    Inflamm Bowel Dis; 2008 Jun; 14(6):794-802. PubMed ID: 18213700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.